The bone marrow (BM) is an organ extremely efficient in mediating long-term survival of plasma cells (PCs), ensuring an immune humoral memory. This implies that the BM must provide continuously key PC survival factors. Our results show that the BM is an organ constitutively rich in a proliferation-inducing ligand (APRIL), a member of the tumor necrosis factor superfamily implicated in PC survival. APRIL production is induced during hematopoiesis in myeloid cells by non-lineage-committing factors such as stem cell factor, thrombopoietin, IL-3, and FMS-like tyrosine kinase 3 ligand. Notably, APRIL production, both in the human and mouse systems, peaks in myeloid precursor cells, before dropping in fully mature granulocytes. Myeloid cells secr...
Multiple myeloma (MM) is a progressive disease that is thought to result from mul-tiple genetic insu...
Multiple myeloma is a bone marrow plasma cell tumor which is supported by the external growth factor...
International audienceSince the first identification of interleukin (IL)-6 as a myeloma cell growth ...
Multiple myeloma (MM) is a non-curable tumor developing in the bone marrow (BM). The BM microenviron...
According to commonly held concepts, plasma cell (PC) longevity in bone marrow (BM) depends upon the...
The bone marrow constitutes a favorable environment for long-lived antibody-secreting plasma cells, ...
The persistence of serum IgG antibodies elicited in human infants is much shorter than when such res...
The persistence of serum IgG antibodies elicited in human infants is much shorter than when such res...
Multiple myeloma (MM) invariably develops in the bone marrow (BM), indicating the strong requirement...
A proliferation-inducing ligand (APRIL) is a new tumor necrosis factor family member implicated in t...
Here we show that overexpression or activation of B-cell maturation antigen (BCMA) by its ligand, a ...
<div><p>Multiple myeloma is a bone marrow plasma cell tumor which is supported by the external growt...
Plasma cells secrete the antibodies associated with beneficial and adverse immune responses. Two kin...
Long-lived humoral immunity is manifested by the ability of bone marrow plasma cells (PCs) to surviv...
AbstractLong-lived plasma cells (PCs) contribute to humoral immunity through an undefined mechanism....
Multiple myeloma (MM) is a progressive disease that is thought to result from mul-tiple genetic insu...
Multiple myeloma is a bone marrow plasma cell tumor which is supported by the external growth factor...
International audienceSince the first identification of interleukin (IL)-6 as a myeloma cell growth ...
Multiple myeloma (MM) is a non-curable tumor developing in the bone marrow (BM). The BM microenviron...
According to commonly held concepts, plasma cell (PC) longevity in bone marrow (BM) depends upon the...
The bone marrow constitutes a favorable environment for long-lived antibody-secreting plasma cells, ...
The persistence of serum IgG antibodies elicited in human infants is much shorter than when such res...
The persistence of serum IgG antibodies elicited in human infants is much shorter than when such res...
Multiple myeloma (MM) invariably develops in the bone marrow (BM), indicating the strong requirement...
A proliferation-inducing ligand (APRIL) is a new tumor necrosis factor family member implicated in t...
Here we show that overexpression or activation of B-cell maturation antigen (BCMA) by its ligand, a ...
<div><p>Multiple myeloma is a bone marrow plasma cell tumor which is supported by the external growt...
Plasma cells secrete the antibodies associated with beneficial and adverse immune responses. Two kin...
Long-lived humoral immunity is manifested by the ability of bone marrow plasma cells (PCs) to surviv...
AbstractLong-lived plasma cells (PCs) contribute to humoral immunity through an undefined mechanism....
Multiple myeloma (MM) is a progressive disease that is thought to result from mul-tiple genetic insu...
Multiple myeloma is a bone marrow plasma cell tumor which is supported by the external growth factor...
International audienceSince the first identification of interleukin (IL)-6 as a myeloma cell growth ...